Popular Pharmaceuticals PLC

31/12/2025

09/12/2025

A fresh new chapter begins today!

Popular Pharma, Ophthalmic Business Unit is proudly introducing a unique Anti Glaucoma fixed dose combination in Preservative Free Novelia Device “Betafree” (Brinzolamide USP 1% + Brimonidine Tartrate BP 0.2%) 5ml.

“Betablocker Free Combination in Preservative Free Innovation”.

Betafree is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.

01/12/2025

Popular Pharmaceuticals proudly presents Rosu EZ (Rosuvastatin & Ezetimibe Tablet) — a high-intensity combination therapy designed to support effective LDL-C reduction.
✨ Why Rosu EZ?
❤ Clinically effective & well-tolerated
❤ Convenient single-tablet regimen to reduce pill burden
❤ Multiple strengths to meet individual patient needs
❤ A trusted choice recommended by EAS & ESC
Take a step toward better heart health with Rosu EZ.
Popular Pharmaceuticals PLC – Committed to healthier lives.

01/12/2025

A Breakthrough News

Popular Pharmaceuticals PLC- General Unit proudly introducing Renash 60 mg, 80 mg & 100 mg tablets (Resmetirom INN).

The 1st & only US-FDA approved therapy for NASH with Moderate to Advanced Liver Fibrosis.

Renash is a Thyroid Hormone Receptor Beta Agonist, an orally once-daily medication designed to help improve the resolution of steatohepatitis and liver fibrosis.



Key Highlights:

NASH Resolution Without Fibrosis Progression: Delivers histological NASH improvement with sustained liver protection
Proven Fibrosis Improvement: Improves fibrosis by at least 1 stage with no worsening of NAFLD activity score
Significant LDL-Cholesterol Reduction: Helps improve cardiometabolic risk profile in NASH patients
Reduces Intrahepatic Hypothyroidism: Optimizes hepatic thyroid hormone activity - a key driver in NASH pathology
* It’s a new day for Liver Care*

04/11/2025

Great News!
Popular Pharmaceuticals PLC – Chronic Care Unit proudly introducing Galvid 50 (Vildagliptin INN 50 mg Tablet), Trusted Gliptin for Type 2 Diabetes Mellitus (T2DM).
Galvid 50 is a DPP-4 inhibitor designed to ensure effective, safe and sustained glycemic control in patients with Type 2 Diabetes Mellitus.
Key Highlights:
• Helps to maintain HbA1c, FPG & PPG within target range
• DMF Grade raw material ensures efficacy, quality and consistency
• Can be used alone or in combination with other antidiabetic agents

20/10/2025

সুস্থ হাড় গড়ি, জীবন সুন্দর করি

15/08/2025

"আসুন ডায়াবেটিস প্রতিরোধ করি"
Speaker: Prof. Dr. Farid Uddin
Founder Chairman, Dept. of Endocrinology
Bangladesh Medical University (PG Hospital)
Professor of Endocrinology (Honorary)
Popular Medical College.

10/08/2025

🌟 Great News from Popular Pharmaceuticals PLC (CCT)!
Introducing Verivas (Vericiguat 2.5mg / 5mg / 10mg)
A true friend in the management of Chronic Heart Failure (HFrEF) ❤️
🔷 Recommended by:
AHA | ACC | HFSA
🔶 Key Benefits:
✔️ Improves heart function & vascular tone
✔️ Reduces HF hospitalization risk by up to 10%
✔️ Lowers CV death & hospitalization event rate by 4.2%
✔️ Safe & well-tolerated for chronic HF patients

02/08/2025

🌍 Iron Deficiency Anemia is a Global Burden — Let’s Tackle It Effectively!

Popular Pharmaceuticals PLC. proudly introduces Malferin (Ferric Maltol INN 30mg ) Capsule:
✅ Gentle on the stomach
✅ Clinically proven iron absorption
✅ Better tolerability than conventional iron salts
✅ Helps restore iron levels and energy

Many people struggle with iron supplements due to stomach upset and poor absorption. Malferin offers a modern solution — delivering effective iron replenishment with fewer side effects, helping patients stay on therapy and achieve target iron levels.

💡 Why Choose Malferin?
🔬 Innovative formulation
🔒 Reduced gastrointestinal discomfort
📈 Improves compliance & outcomes

Together with Malferin, let’s fight iron deficiency anemia — for a healthier, stronger tomorrow.